Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Factor VIII Deficiency Disease With Inhibitor”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableStudy completedNCT06357572
What this trial is testing

Real-life Clinical FEIBA Samples Measured Using the Version A of the HemA EnzySystem

Who this might be right for
Hemophilia A With InhibitorHemophilia A
Enzyre B.V. 6
Post-approval studies (Phase 4)Looking for participantsNCT05888870
What this trial is testing

ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor

Who this might be right for
Hemophilia A With Inhibitor
Institute of Hematology & Blood Diseases Hospital, China 50
Post-approval studies (Phase 4)UnknownNCT06320626
What this trial is testing

Pharmacokinetic-guided Dosing of Emicizumab

Who this might be right for
Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia A, Severe+3 more
Kathelijn Fischer 95
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Post-approval studies (Phase 4)Looking for participantsNCT04647227
What this trial is testing

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
American Thrombosis and Hemostasis Network 55
Not applicableStudy completedNCT03818529
What this trial is testing

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Who this might be right for
HemophiliaHemophilia AHemophilia B+5 more
American Thrombosis and Hemostasis Network 237
Not applicableStudy completedNCT03372993
What this trial is testing

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency+1 more
AryoGen Pharmed Co. 200
Testing effectiveness (Phase 2)Study completedNCT03407651
What this trial is testing

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 11
Post-approval studies (Phase 4)Study completedNCT01800435
What this trial is testing

A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor

Who this might be right for
Hereditary Factor VIII Deficiency Disease With Inhibitor
Oslo University Hospital 6
Not applicableStudy completedNCT04165135
What this trial is testing

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

Who this might be right for
Severe Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A
Hoffmann-La Roche 103
Large-scale testing (Phase 3)Active Not RecruitingNCT06312475
What this trial is testing

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Suzhou Alphamab Co., Ltd. 53
Post-approval studies (Phase 4)Active Not RecruitingNCT04205175
What this trial is testing

Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab

Who this might be right for
Hemophilia A With Inhibitor
Children's Hospital Los Angeles 20
Not applicableUnknownNCT01505946
What this trial is testing

Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors

Who this might be right for
Severe Hemophilia A With Inhibitor
Grifols Italia S.p.A 25
Not applicableStudy completedNCT03951103
What this trial is testing

RFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia A

Who this might be right for
Hemophilia A With Inhibitor
Swedish Orphan Biovitrum 44
Testing effectiveness (Phase 2)Ended earlyNCT04548791
What this trial is testing

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders

Who this might be right for
Factor VII DeficiencyGlanzmann ThrombastheniaHemophilia A With Inhibitor
Catalyst Biosciences 19
Not applicableLooking for participantsNCT05802836
What this trial is testing

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Who this might be right for
Severe Hemophilia ASevere Hemophilia A With InhibitorSevere Hemophilia A Without Inhibitor
Christoph Königs 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT07158606
What this trial is testing

Understanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance Induction

Who this might be right for
Hemophilia A With Inhibitor
Versiti Blood Health 15
Post-approval studies (Phase 4)UnknownNCT03598725
What this trial is testing

Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China

Who this might be right for
Hemophilia A With Inhibitor
Beijing Children's Hospital 55
Post-approval studies (Phase 4)Looking for participantsNCT06864975
What this trial is testing

Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)

Who this might be right for
Hemophilia a with Inhibitor
Runhui WU 110
Large-scale testing (Phase 3)Study completedNCT04158648
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

Who this might be right for
Mild Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHemophilia A
Hoffmann-La Roche 73
Next Page